Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,441.78
+32.661.36%
Number of Gainers:62
Number of Losers:35
Number of Flat:- -
PE:- -
High:2,444.66
Open:2,409.60
Low:2,409.60
Close:2,409.12
Volume:1.33B
Turnover:290.12B
Market Cap:51.17T
Float Cap:47.82T

Loading ...

Apple Buy Rating Reaffirmed as Analyst Sees Strong iPhone 18 Trends, AI Upside and Keeps Price Target Unchanged at $370

TIPRANKS
·
Sep 14

Oracle Begins a New Round of Layoffs- Business Insider

THOMSON REUTERS
·
Sep 14

European Car Industry Could Continue to Lose Market Share to Chinese Peers

Dow Jones
·
Sep 14

Oracle Price Target Maintained with a $225.00/Share by Argus Research

Dow Jones
·
Sep 14

Verizon Targets 2028 Los Angeles Olympics as Proving Ground for AI-Native 6G Network Plans

Reuters
·
Sep 14

BioMarin Appoints Bristol Myers Squibb Research Chief Robert Plenge to Board

Reuters
·
Sep 14

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Sep 14

Oracle Hosts Health and Life Sciences Summit in Orlando

Reuters
·
Sep 14

LIVE Markets-AI Weakness, Fed Looming as NASDAQ Poised to Test Support

Reuters
·
Sep 14

Verizon Adds AWS, Cisco, Intel, Nvidia to 6G Innovation Forum Consortium

Reuters
·
Sep 14

Press Release: BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

Dow Jones
·
Sep 14

ADT Brings DIY Home Security System ADT Blu to Walmart.com Marketplace

Reuters
·
Sep 14

PayPal’s $50 Billion Escape Route Stalled—Can Lores Win Alone?

Smartkarma
·
Sep 14

Dow to Join Morgan Stanley Laguna Conference Fireside Chat

Reuters
·
Sep 14

Notable open interest changes for September 14th

TIPRANKS
·
Sep 14

Oracle Health Clinical AI Agent Helps Nurses Alleviate Documentation Burden and Streamline Care

THOMSON REUTERS
·
Sep 14

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Sep 14

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Sep 14

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Sep 14

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS
·
Sep 14